日時: 2021年12月23日 (木曜日)時間: 18:00 (日本標準時)以降はオンデマンドで視聴可能です。
所要時間: 45 分
概要
敗血症診療における乳酸値測定の意義を ガイドライン策定メンバーでもある 札幌医科大学 医学部 集中治療学 准教授 巽 博臣先生にお話しいただきました。
敗血症診療にかかわる先生方、あるいは、簡単で素早い乳酸値測定法が気になる先生方、必見のウェビナーです。
「日本版敗血症診療ガイドライン2020」は、2016年版からどう進化したのか、どのように捉えるべきものなのか。
「重症患者への栄養療法」を駆使する演者の眼から、気をつけたいCQ（例：敗血症患者への栄養投与は経腸栄養と経静脈栄養のどちらを行うか？）のピックアップ解説。
続く後段で、敗血症診療における迅速な乳酸値測定の意義に関して、腸管壊死の症例とその際の乳酸値データ推移の事例を紹介しつつ考察。
演者
巽 博臣 先生(Dr.Hiroomi TATSUMI)
札幌医科大学 医学部 集中治療学 准教授
Date: Wednesday, March 31, 2021 Time: 1:00 PM EDT
Date: Thursday, April 15, 2021 Time: 1:00 PM EDT
Duration: 1 hour
Urea and creatinine have been key indicators of kidney function for years and can be measured easily and quickly with currently available whole blood point of care analyzers. While newer tests for assessing renal function may hold promise for the future, they currently lack the history and clinical familiarity of urea, creatinine, and their ratio. In addition, the urea:creatinine ratio still has significant value in selected patient populations, particularly critically ill patients, COVID-19 patients, and trauma patients. This webinar will describe the biochemisty of urea and creatinine production, and the physiology and handling of these metabolites by the kidneys as a lead-in to a discussion of the urea:creatinine ratio. New clinical studies will be summarized that describe the utility of the urea:creatinine ratio as a rapid, easy to obtain parameter to gauge the severity of the illness and the likelihood of survival in COVID-19, sepsis, and trauma patients.
Learning Objectives
Educational Credits
This program offers 1 hour of P.A.C.E. continuing education credits.
This program has been approved by the American Association of Critical Care Nurses (AACN), for 1.00 CERPs, Synergy CERP Category A, File Number 23540. Approval refers to recognition of continuing education only and does not imply AACN approval or endorsement of the content of this educational activity, or the products mentioned.Speakers
John Toffaletti, Ph.D.
Professor of Pathology, Director of ABG and CPED Labs
Duke University Medical Center
Dennis Begos, MD, FACS, FACRS
Associate Medical Director, Medical and Scientific Affair
Nova Biomedical
Duration: 58 minutes
Sepsis remains a one of the major causes of death in all levels of veterinary practice. Early diagnosis and rapid treatment is essential for recovery. Knowing the pathological processes of sepsis will aid in diagnosis and management. This webinar will review the role of the neutrophils in development of organ failure.
Learning Objectives:
Continuing Education:
This program 1200-31297 is approved by the AAVSB RACE to offer a total of 1.00 CE Credits (1.00 max) being available to any one veterinarian: and/or 1.00 Veterinary Technician CE Credits (1.00 max). This RACE approval is for the subject matter categories of:
Category One: Scientific using the delivery method of Interactive-Distance.
This approval is valid in jurisdictions which recognize AAVSB RACE; however, participants are responsible for ascertaining each board’s CE requirements. RACE does not “accredit” or “endorse” or “certify” any program or person, nor does RACE approval validate the content of the programSpeakers
Federico Montealegre-Golcher, DVM, MS, PhD
Director, MASA LATAM
Nova Biomedical
Regional Medical Director with over 15 years of experience in Medical Affairs and Scientific Affairs generating, executing protocols, publishing and communicating scientific data to external and internal audiences. 10 years in the Pharmaceutical Industry in LATAM developing and managing productive relationships with Key Opinion and Scientific Leaders. Background includes extensive clinical trials Phases I-IV and research in therapeutic areas including Immunology, Neurology, Oncology and Rare Diseases. Fully Trilingual: English, Spanish and Brazilian Portuguese.